Use of Siglec-7 or Siglec-9 antibodies for the treatment of cancer
- 专利权人:
- Palleon Pharmaceuticals Inc.
- 发明人:
- Broderick, James,Normington, Karl D.
- 申请号：
- AU2017207807
- 公开号：
- AU2017207807A1
- 申请日:
- 2017.01.12
- 申请国别(地区):
- AU
- 年份:
- 2018
- 代理人:
- 摘要：
- The present application provides compositions and methods for treating a patient with cancer, and in particular epithelial tumors and carcinomas, with antibodies directed to CD33- like Siglecs.
- 来源网站：
- 中国工程科技知识中心
